Antonius Schuh, Ph.D. Joins TrovaGene, Inc. As Chief Executive Officer - MarketWatch (press release) Print
MarketWatch (press release)
"The company has made significant efforts to establish the utility of trans-renal nucleic acids in urine as a diagnostic sample in clinical fields as diverse as detection of minimal residual disease in oncology, infectious disease, transplant medicine

...